The GLP-1 gut motility paradox: why some get constipation and others get diarrhea Here's the pattern that confuses patients: in the STEP 1 trial, 23.7% of semaglutide patients reported constipation, but 8.2% reported diarrhea
These include reflections on the concept of justice itself being notably absent from city planning documents, the lack of methodological frameworks and metrics for evaluating justice-related outcomes of street transformations, and limited institutional capacities for community engagement, frequently resulting in superficial consultation processes
Microdosing involves administering smaller doses of medication to tailor the treatment to the patient's needs, significantly reducing side effects compared to standard dosing
These changes can create temporary disruption before improvement emerges
described a case of melanotan-induced priapism [20]
Gasoyans PhD dissertation concerned the underutilization of bariatric surgery for treatment of obesity